HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric P Krenning Selected Research

Melanoma (Melanoma, Malignant)

10/2006Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.
12/2003In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric P Krenning Research Topics

Disease

86Neoplasms (Cancer)
02/2024 - 04/2002
34Neuroendocrine Tumors (Neuroendocrine Tumor)
03/2021 - 04/2002
13Neoplasm Metastasis (Metastasis)
01/2018 - 06/2002
8Thyroid Neoplasms (Thyroid Cancer)
02/2016 - 06/2002
6Prostatic Neoplasms (Prostate Cancer)
03/2019 - 01/2007
4Carcinoid Tumor (Carcinoid)
04/2008 - 08/2007
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2023 - 01/2013
3Diabetes Mellitus
05/2010 - 06/2003
3Proteinuria
05/2007 - 04/2002
3Pituitary Neoplasms (Pituitary Adenoma)
04/2007 - 12/2003
3Breast Neoplasms (Breast Cancer)
04/2004 - 03/2003
2Disease Progression
01/2022 - 12/2021
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2021 - 01/2007
2Diarrhea
03/2021 - 09/2011
2Adenocarcinoma
10/2020 - 06/2007
2Colonic Neoplasms (Colon Cancer)
10/2020 - 06/2020
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2017 - 05/2016
2Gastro-enteropancreatic neuroendocrine tumor
05/2014 - 09/2010
2Vomiting
09/2011 - 01/2003
2Renal Insufficiency (Renal Failure)
12/2010 - 01/2007
2Hypertension (High Blood Pressure)
05/2010 - 04/2002
2Hodgkin Disease (Hodgkin's Disease)
06/2009 - 04/2003
2Carcinoma (Carcinomatosis)
04/2008 - 10/2006
2Pheochromocytoma
04/2008 - 01/2007
2Paraganglioma (Paragangliomas)
01/2007 - 10/2006
2Melanoma (Melanoma, Malignant)
10/2006 - 12/2003
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2006 - 08/2002
2Lymphatic Metastasis
04/2004 - 03/2003
2Cardiomyopathies (Cardiomyopathy)
06/2003 - 09/2002
1Inflammation (Inflammations)
01/2022
1Virus Diseases (Viral Diseases)
01/2022
1Critical Illness (Critically Ill)
01/2022
1COVID-19
01/2022
1Cytokine Release Syndrome
01/2022
1Flushing
03/2021

Drug/Important Bio-Agent (IBA)

38Somatostatin Receptors (Somatostatin Receptor)IBA
02/2024 - 04/2002
36Radioisotopes (Radionuclides)IBA
02/2024 - 04/2002
36Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
02/2024 - 04/2002
26Peptide Receptors (Peptide Receptor)IBA
01/2020 - 12/2002
231,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
03/2022 - 04/2002
21Peptides (Polypeptides)IBA
11/2020 - 12/2002
20Octreotide (Sandostatin)FDA LinkGeneric
12/2021 - 04/2002
18Pentetic Acid (DTPA)FDA LinkGeneric
05/2014 - 04/2002
14Tyr(3)- octreotateIBA
11/2015 - 04/2002
12Bombesin Receptors (Bombesin Receptor)IBA
11/2020 - 01/2007
11BombesinIBA
03/2019 - 12/2002
10Neprilysin (Neutral Endopeptidase)IBA
11/2020 - 01/2014
8AcidsIBA
04/2008 - 12/2002
7phosphoramidonIBA
11/2020 - 01/2014
73-Tyr-octreotideIBA
03/2010 - 04/2002
6NeurotensinIBA
10/2023 - 01/2005
6Cholecystokinin (Pancreozymin)IBA
03/2022 - 07/2009
6GastrinsIBA
03/2022 - 07/2009
5Lysine (L-Lysine)FDA Link
11/2014 - 12/2005
5yttrium(III)- 1,4,7,10- tetraazacyclotetradecane- N,N',N'',N'''- tetraacetic acidIBA
03/2010 - 01/2005
5RadiopharmaceuticalsIBA
07/2009 - 04/2002
4lutetium Lu 177 dotatateIBA
12/2021 - 05/2014
4Gastrin-Releasing PeptideIBA
11/2013 - 12/2002
4Folic Acid (Vitamin M)FDA LinkGeneric
07/2011 - 08/2007
4pentetreotide (OctreoScan)FDA Link
05/2010 - 04/2003
4177Lu-octreotateIBA
08/2007 - 10/2003
3minigastrinIBA
02/2016 - 03/2003
3Amifostine (Ethyol)FDA LinkGeneric
05/2012 - 01/2007
3Amino AcidsFDA Link
12/2010 - 04/2002
3CreatinineIBA
05/2007 - 04/2002
3Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
04/2007 - 12/2003
3Therapeutic UsesIBA
07/2004 - 04/2002
2hydroxide ionIBA
10/2023 - 06/2007
2Chelating AgentsIBA
03/2022 - 10/2003
2sacubitril and valsartan sodium hydrate drug combinationIBA
11/2020 - 10/2020
2Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2020 - 06/2020
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2020 - 06/2020
2Lisinopril (Prinivil)FDA LinkGeneric
10/2020 - 06/2020
2Vasopeptidase InhibitorsIBA
10/2020 - 12/2016
268Ga-SB3IBA
03/2019 - 01/2017
2Chromogranin AIBA
01/2018 - 09/2011
2Arginine (L-Arginine)FDA Link
12/2010 - 12/2005
2Hormones (Hormone)IBA
09/2010 - 04/2008
2AndrogensIBA
06/2010 - 01/2007
2Substance PIBA
07/2009 - 01/2005
2Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
07/2009 - 04/2008
2indium-111-octreotideIBA
07/2009 - 01/2005
2Folic Acid AntagonistsIBA
04/2008 - 08/2007
2Pemetrexed (MTA)FDA Link
04/2008 - 08/2007
2DobutamineFDA LinkGeneric
01/2006 - 09/2002
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2006 - 06/2003
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2006 - 08/2002
2Cholecystokinin B ReceptorIBA
04/2004 - 03/2003
1neurotensin (8-13)IBA
10/2023
1AminesIBA
10/2023
11- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
03/2022
1Lidocaine (Xylocaine)FDA LinkGeneric
01/2022
1Adenosine Triphosphate (ATP)IBA
01/2022
1Purinergic Receptors (Receptors, Purine)IBA
01/2022

Therapy/Procedure

51Therapeutics
02/2024 - 04/2002
9Aftercare (After-Treatment)
07/2020 - 04/2003
8Precision Medicine
02/2024 - 01/2017
8Radiotherapy
01/2018 - 12/2002
7Drug Therapy (Chemotherapy)
01/2018 - 08/2002
2Castration
06/2010 - 01/2007